TickerFacts.

Candel Therapeutics, Inc. (CADL): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$33.94M
Year ended 2022-12-31
2020-12-31: -$13.72M2021-12-31: -$25.49M2022-12-31: -$33.94M-$33.94M
2020-12-31 EBITDA (USD) 2022-12-31
Period endedEBITDAChange YoYSource filing
2022-12-31-$33.94Mn/m2024-03-28, From 2022-01-01
2021-12-31-$25.49Mn/m2023-03-30, From 2021-01-01
2020-12-31-$13.72Mn/a2022-03-29, From 2020-01-01